健友股份,603707,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,2435,675,1760,72.28%,2.09% 国内制剂,35751,6547,29204,81.69%,34.72% 其他(补充),171,169,2,1.28%,0% 国外制剂,4091,2800,1291,31.56%,1.53% CDMO,9211,5359,3852,41.82%,4.58% 标准肝素原料药,118374,70374,47999,40.55%,57.07% 健友股份,603707,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3749,1822,1926,51.39%,3.73% 其他产品,4649,4357,292,6.29%,0.57% 低分子肝素制剂,10993,3551,7442,67.69%,14.42% 标准肝素原料药,91882,49938,41944,45.65%,81.28% 健友股份,603707,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,385,186,199,51.72%,0.81% 其他(补充),2562,1441,1121,43.76%,4.58% 低分子肝素原料,764,279,485,63.44%,1.98% 标准肝素原料,47107,27896,19211,40.78%,78.44% 低分子肝素制剂,3741,2221,1521,40.65%,6.21% 其他制剂,3631,1677,1954,53.8%,7.98% 健友股份,603707,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),676,170,506,74.8%,3.93% 其他产品,1049,409,640,61.03%,4.98% 低分子肝素原料,596,234,362,60.67%,2.81% 低分子肝素制剂,2942,2034,908,30.85%,7.06% 标准肝素原料,41609,31161,10449,25.11%,81.22% 健友股份,603707,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1297,188,1109,85.52%,12.34% 其他产品,459,253,206,44.88%,2.29% 低分子肝素制剂,39,88,-49,-123.47%,-0.54% 标准肝素原料,39816,32094,7722,19.4%,85.91%